GUALTIEROTTI, ROBERTA
GUALTIEROTTI, ROBERTA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation
2026 F. Malvestiti, A. Lombardi, F. Gentile, V. Torcianti, E. Trombetta, A. Cherubini, G. Lamorte, S.C.U. Renteria, D. Marchelli, L. Rosso, A. Bandera, F. Peyvandi, F. Blasi, G. Grasselli, L. Porretti, S. Alqahtani, D. Prati, R. Gualtierotti, B. Soskic, V. Vaira, L. Ronzoni, L. Valenti
Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels
2026 L. Miano, E. Sinopoli, A. Cherubini, C. Suffritti, S. Pelusi, F. Rahmeh, G.E. Lamorte, F. Peyvandi, F. Blasi, G. Grasselli, A. Bandera, R. Gualtierotti, D. Prati, L.V.C. Valenti
Platelet function abnormalities in acquired hemophilia A
2026 R. Rossio, A. Lecchi, S. La Marca, L. Padovan, R. Gualtierotti, C. Novembrino, C. Suffritti, S. Arcudi, A. Ciavarella, F. Boggio, S.M. Siboni, F. Peyvandi
Artificial Intelligence for Automated Detection of Joint Bleeding via Ultrasound in Hemophilia: Advancing Standardization
2026 R. Gualtierotti, A. Giachi, S. Arcudi, A. Truma, C. Suffritti, M. Colussi, M. Manzoni, D. Ahmetovic, S.A. Angileri, G. Carrafiello, S. Mascetti, C. Bettini, F. Peyvandi
Sex Differences in Cancer-Associated Thrombosis
2026 A. Giachi, D. Santagata, A. Truma, A. Artoni, P. Bucciarelli, L. Valenti, C. Ay, R. Gualtierotti
Gene therapy in hemophilia: the dawn of a new era
2025 R. Gualtierotti, A. Giachi, N. Bitto, V. La Mura, F. Peyvandi
Bridging the gap: Time to integrate sex and gender differences into research and clinical practice for improved health outcomes
2025 R. Gualtierotti
A Challenging Case of Immune-Related Organizing Pneumonitis Following Programmed Cell Death 1 Inhibitor Therapy in Non-Small Cell Lung Cancer
2025 G. Paolozzi, R. Gualtierotti, R. Rossio, B. Ferrari, N. Bitto, F. Peyvandi
Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry
2025 A. Tripodi, M. Clerici, E. Scalambrino, S. Arcudi, R. Gualtierotti, C. Novembrino, F. Peyvandi
Involvement of the contact pathway in COVID-19 coagulopathy
2025 M. Capecchi, C. Novembrino, M. Abbattista, M. Boscolo-Anzoletti, E. Galbiati, S. Griffini, E. Grovetti, L. Valenti, F. Blasi, G. Grasselli, R. Gualtierotti, M. Cugno, F. Peyvandi
Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half‐Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study
2025 L.P. Solimeno, R. Gualtierotti, E. Guido, J. Acquati Lozej, E. Cristini, A. Ciavarella, S. Arcudi, C. Carulli, L. Pieri, S.M. Siboni, F. Peyvandi
Thickening of the Intramuscular Fascia of the Iliacus Muscle as Evidence of Myofascial Pathology: A New Hip Pain Syndrome
2025 S.M. Stella, A. Saponara, R. Gualtierotti, F. Vita, M. Miccoli, M. Becciolini, S. Galletti, F. Cotellessa, C. Trompetto
Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimization
2025 C. Suffritti, R. Gualtierotti, A. Zanichelli, M. Vidali, M. Cugno
Interactive Guidance for Self-Acquisition of Ultrasound Images by Hemophilic Patients
2025 D. Ahmetovic, C. Bettini, M. Colussi, S. Giacoia, R. Gualtierotti, M. Manzoni, S. Mascetti, F. Peyvandi
Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): recommendations from Italian scientific societies, patient associations and regulators
2025 E.D. Stea, M. Pugliano, R. Gualtierotti, M. Mazzucato, L. Santangelo, G. Annicchiarico, A. Berardelli, S. Bianchi, L. Bogliolo, P. Chiandotto, G. Cirino, F.D. Iaco, S.D. Rosa, F. Dentali, P. Facchin, E.G. Favalli, F. Fiorin, A. Giarratano, C. Laterza, F. Macrì, M. Mancuso, A. Padovani, A. Pasini, A.M. Scopinaro, G.D. Sebastiani, G. Sesti, B. Susi, A. Torsello, C. Vezzoni, L. Zanlari, L. Gesualdo, A.D. Luca
Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging
2024 R. Gualtierotti, A. Giachi, A. Truma, S. Arcudi, A. Ciavarella, P. Bucciarelli, D. Consonni, E. Boccalandro, V. Begnozzi, L.P. Solimeno, S.M. Siboni, F. Peyvandi
Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19
2024 R. Rossio, M. Tettamanti, A.A. Galbussera, R. Gualtierotti, A. Giachi, A. Torri, N. Montano, A.L. Fracanzani, A. Bandera, A. Nobili, F. Peyvandi
The value‐based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia
2024 P.A. Cortesi, C. Fornari, S. Conti, B. Pollio, E. Boccalandro, A. Buzzi, C. Carulli, A. Coppola, R. De Cristofaro, M.N.D. Di Minno, G. Dolan, E. Ferri Grazzi, A. Fornari, R. Gualtierotti, C. Hermans, V. Jiménez‐juste, G. Kenet, A. Lupi, C. Martinoli, M.F. Mansueto, G. Nicolò, A. Tagliaferri, A. Gringeri, A.C. Molinari, L.G. Mantovani, G. Castaman
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome
2024 P. Agosti, S.M. Siboni, A. Ciavarella, S. Arcudi, F. Boggio, R. Gualtierotti, F. Peyvandi
Gender equity in hemophilia: need for healthcare, familial, and societal advocacy
2024 R. Gualtierotti, I. Garagiola, M. Mortarino, S. Spena, O. Romero-Lux, F. Peyvandi